These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21972551)

  • 21. The evolution of seasonal influenza viruses.
    Petrova VN; Russell CA
    Nat Rev Microbiol; 2018 Jan; 16(1):47-60. PubMed ID: 29081496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control.
    Hilleman MR
    Vaccine; 2002 Aug; 20(25-26):3068-87. PubMed ID: 12163258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antigenic evolution of influenza virus and the implications for influenza vaccine development].
    An YM; Zhou X; Wang YC; Huang WJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Nov; 55(11):1339-1345. PubMed ID: 34749479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic.
    Kilbourne ED; Smith C; Brett I; Pokorny BA; Johansson B; Cox N
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10748-52. PubMed ID: 12136133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recommended composition of influenza virus vaccines for use in the 2017 southern hemisphere influenza season.
    Wkly Epidemiol Rec; 2016 Oct; 91(41):469-84. PubMed ID: 27758094
    [No Abstract]   [Full Text] [Related]  

  • 26. In Silico Vaccine Strain Prediction for Human Influenza Viruses.
    Klingen TR; Reimering S; Guzmán CA; McHardy AC
    Trends Microbiol; 2018 Feb; 26(2):119-131. PubMed ID: 29032900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Slowing Influenza Virus Evolution: A Role for Multiple Synergistic Antiviral Specificities in Vaccination Strategies.
    Lafont BAP; Bennink JR
    Viral Immunol; 2020 Apr; 33(3):197-200. PubMed ID: 32286176
    [No Abstract]   [Full Text] [Related]  

  • 28. Acceptable protective efficacy of influenza vaccination in young military conscripts under circumstances of incomplete antigenic and genetic match.
    Pyhälä R; Haanpää M; Kleemola M; Tervahauta R; Visakorpi R; Kinnunen L
    Vaccine; 2001 Apr; 19(23-24):3253-60. PubMed ID: 11312022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2012 Oct; 87(42):401-12. PubMed ID: 23113329
    [No Abstract]   [Full Text] [Related]  

  • 30. The Molecular Determinants of Antibody Recognition and Antigenic Drift in the H3 Hemagglutinin of Swine Influenza A Virus.
    Abente EJ; Santos J; Lewis NS; Gauger PC; Stratton J; Skepner E; Anderson TK; Rajao DS; Perez DR; Vincent AL
    J Virol; 2016 Sep; 90(18):8266-80. PubMed ID: 27384658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2014 Mar; 89(11):105-15. PubMed ID: 24707515
    [No Abstract]   [Full Text] [Related]  

  • 32. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2013 Oct; 88(42):449-63. PubMed ID: 24159668
    [No Abstract]   [Full Text] [Related]  

  • 33. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2013 Mar; 88(11):117-25. PubMed ID: 23544238
    [No Abstract]   [Full Text] [Related]  

  • 34. Applying Unique Molecular Identifiers in Next Generation Sequencing Reveals a Constrained Viral Quasispecies Evolution under Cross-Reactive Antibody Pressure Targeting Long Alpha Helix of Hemagglutinin.
    Hauck NC; Kirpach J; Kiefer C; Farinelle S; Maucourant S; Morris SA; Rosenberg W; He FQ; Muller CP; Lu IN
    Viruses; 2018 Mar; 10(4):. PubMed ID: 29587397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2014 Oct; 89(42):457-64. PubMed ID: 25337626
    [No Abstract]   [Full Text] [Related]  

  • 36. The generation of influenza outbreaks by a network of host immune responses against a limited set of antigenic types.
    Recker M; Pybus OG; Nee S; Gupta S
    Proc Natl Acad Sci U S A; 2007 May; 104(18):7711-6. PubMed ID: 17460037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2018 Mar; 93(12):142-52. PubMed ID: 29569430
    [No Abstract]   [Full Text] [Related]  

  • 38. Evolution of Influenza A Virus by Mutation and Re-Assortment.
    Shao W; Li X; Goraya MU; Wang S; Chen JL
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28783091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution, safety, and highly pathogenic influenza viruses.
    Lipsitch M; Plotkin JB; Simonsen L; Bloom B
    Science; 2012 Jun; 336(6088):1529-31. PubMed ID: 22723411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The results of a study of the data obtained from patients vaccinated earlier with different influenza vaccines].
    Ivanova VT; Slepushkin AN; Burtseva EI; Oskerko TA; Golubeva LI; Beliaev AL
    Vopr Virusol; 1994; 39(2):66-8. PubMed ID: 8017055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.